Sitacip M 50mg/500mg Tablet ER
By Sitacip M
Rx
10 Tablet ER in a Strip

Composition
Sitagliptin(50mg) + Metformin(500mg)

Manufacturer - Cipla Ltd
Cipla House, Peninsula Business Park, Ganpatrao Kadam Marg, Lower Parel, Mumbai-400013

Expires on or after
April, 2026
Benefits
Sitacip M 50mg/500mg Tablet ER is a medication used to treat Type 2 diabetes mellitus. It contains a combination of two medicines that work together to lower blood glucose levels. Managing diabetes is crucial in preventing serious complications such as kidney damage, eye damage, nerve issues, and limb loss. By controlling blood sugar levels with this medication, you can also reduce the risk of heart disease and stroke.
The medication works by blocking the action of an enzyme called DPP-4, which plays a key role in regulating insulin production and blood sugar levels. This helps the body produce more insulin only when necessary and prevents the liver from producing excess sugar. By maintaining proper blood sugar levels, Sitacip M 50mg/500mg Tablet ER reduces the risk of complications like retinopathy, nephropathy, neuropathy, diabetic foot ulcers, and delayed wound healing.
Taking Sitacip M 50mg/500mg Tablet ER regularly, along with a balanced diet and exercise, can help you lead a normal and healthy life. It is important to continue using this medication as prescribed to protect your future health. By incorporating this medication into your diabetes management routine, you can effectively control your blood sugar levels and minimize the risk of serious diabetes-related complications.
How to use the Sitacip M 50mg/500mg Tablet ER
To use Sitacip M 50mg/500mg Tablet ER, follow the instructions given by your doctor carefully. This medication should be taken in the dose and duration recommended by your doctor. Swallow the tablet whole with a glass of water, preferably with food. Do not crush, chew, or break the tablet. Your doctor will determine the correct dosage and treatment duration based on factors such as your age, body weight, and the condition being treated. It is important not to stop taking Sitacip M 50mg/500mg Tablet ER unless your doctor specifically advises you to do so. If you have any questions or concerns about how to use this medication, consult your doctor for further guidance.
Uses of Sitacip M 50mg/500mg Tablet ER
Sitacip M 50mg/500mg Tablet ER is commonly used for the treatment of Type 2 diabetes mellitus. It is specifically designed to help manage this condition. Type 2 diabetes mellitus refers to a chronic condition where the body experiences difficulty in utilizing insulin effectively, leading to high blood sugar levels. Patients with type 2 diabetes mellitus can benefit from using Sitacip M 50mg/500mg Tablet ER to help regulate their blood sugar levels and improve overall control of the condition. This medication plays a crucial role in the management of type 2 diabetes mellitus, and when used as per the healthcare provider's instructions, it can support patients in effectively addressing the symptoms and complications associated with this condition.
What conditions Sitacip M 50mg/500mg Tablet ER treats?
Sitacip M 50mg/500mg Tablet ER is used in the management of type 2 diabetes. Type 2 diabetes is a condition where the body struggles to produce enough insulin or utilize it effectively, leading to high blood sugar levels. Symptoms may include increased thirst, frequent urination, slow wound healing, increased hunger, fatigue, and blurred vision. Complications of type 2 diabetes can involve nerve problems, kidney problems, eye damage or blindness, limb amputation, sexual dysfunction, and an elevated risk of heart attack or stroke. Weight fluctuations may also occur in some cases.
Should you consult a doctor?
Seek medical attention if you experience severe, uncontrollable diabetes, nausea, vomiting, diarrhea, rapid weight loss, lactic acidosis, ketoacidosis, dehydration, systemic infection, shock, blood circulation issues, breathing difficulties, are an alcoholic, or scheduled for upcoming X-rays. Inform your doctor before taking Sitacip M 50mg/500mg Tablet ER 50/500 Tablet ER if you have a history of pancreatitis, alcohol dependence, high blood lipids, type I diabetes, major surgery upcoming, fasting, malnutrition, extreme exercise, or vitamin B12 deficiency.
Side effects of Sitacip M 50mg/500mg Tablet ER
Sitacip M 50mg/500mg Tablet ER may cause some side effects while your body adjusts to the medicine. These side effects are generally mild and temporary. Side effects may include decreased appetite, vomiting, upper respiratory tract infections, hypoglycemia (low blood glucose level), abdominal bloating, nausea, and diarrhea. It's essential to keep in mind that not all individuals will experience these side effects, and some may not experience any at all.
Other possible side effects of Sitacip M 50mg/500mg Tablet ER may include drowsiness, dizziness, dry mouth, headache, skin itching, and upper respiratory tract infections like nasopharyngitis. If you notice any of the following severe side effects, stop taking the medication and seek immediate medical attention: serious allergic reactions such as hives, swelling of the face, lips, tongue, or throat leading to difficulty breathing or swallowing; severe blistering of the skin, indicating an allergic skin reaction known as bullous pemphigoid; signs of pancreatitis like severe and persistent stomach pain with or without nausea and vomiting; signs of lactic acidosis such as cold extremities, dizziness, irregular heartbeat, muscle pain, breathing difficulties, sleepiness, stomach pains, nausea, or vomiting.
Further side effects that warrant medical attention include hypoglycemia, nausea, vomiting, flatulence, diarrhea, constipation, stomach pain, loss of appetite, swelling in the hands and legs (edema), stuffy nose, sore throat, and joint or limb pain. It's important to consult your healthcare provider if you experience any persistent or concerning side effects while taking Sitacip M 50mg/500mg Tablet ER.
Safety advice

liver
Sitacip M 50mg/500mg Tablet ER may not be suitable for individuals with liver disease and is advised to be avoided. It is recommended to seek guidance from your doctor before using this medication to ensure safety and effectiveness.

kidney
Sitacip M 50mg/500mg Tablet ER should be used with caution in patients with kidney disease. Dose adjustment may be necessary. Avoid in severe kidney disease. Regular kidney function tests are recommended during use. Consult your doctor.

alcohol
It is not safe to drink alcohol while taking Sitacip M 50mg/500mg Tablet ER.

driving
If you experience symptoms of low or high blood sugar, avoid driving while taking Sitacip M 50mg/500mg Tablet ER as it may impact your ability to drive safely.

pregnancy
Sitacip M 50mg/500mg Tablet ER is not recommended during pregnancy as it may be harmful to the developing baby based on animal studies. Your doctor will assess the potential risks versus benefits before prescribing it to you. Please consult your doctor.

breastfeeding
Caution advised while breastfeeding as Sitacip M 50mg/500mg Tablet ER may be unsafe. Limited data shows drug may pass into breastmilk and harm baby.
Age above 75(Geriatrics)
Sitacip M 50mg/500mg Tablet ER TABLET should be used with caution in elderly patients (aged above 65 years). Therefore, consult your doctor before taking it.
Age below 6 months(Pediatrics)
Sitacip M 50mg/500mg Tablet ER TABLET is not recommended for use in children and adolescents (aged below 18 years). However, consult your doctor before taking it.
Consumption warning before consuming Sitacip M 50mg/500mg Tablet ER
Before taking Sitacip M 50mg/500mg Tablet ER, inform your doctor if you are allergic to sitagliptin, any other medications, foods, or any components present in the tablet. Prolonged use of Sitacip M 50mg/500mg Tablet ER may lead to acute pancreatitis and severe kidney problems. There is an increased risk of low blood sugar levels when Sitacip M 50mg/500mg Tablet ER is combined with other anti-diabetic medications or insulin therapy, requiring potential dosage adjustments. Some patients may experience severe allergic reactions such as anaphylaxis, angioedema, or Stevens-Johnson syndrome while using Sitacip M 50mg/500mg Tablet ER. It is important to note that the safety and effectiveness of Sitacip M 50mg/500mg Tablet ER in individuals under 18 years old have not been established, thus this medication is not recommended for pediatric use. If you are taking digoxin for heart conditions along with Sitacip M 50mg/500mg Tablet ER, close monitoring for potential drug interactions is necessary.
Disease interactions
When considering the use of Sitacip M 50mg/500mg Tablet ER, it is important to take into account certain factors related to specific health conditions. Patients with a history of pancreatitis or pancreatic disease should use Alsita-50 Tab 10'S with caution. Additionally, individuals with renal dysfunction should also be cautious when using this medication. It is advisable to consult with a healthcare professional before starting Sitacip M 50mg/500mg Tablet ER if you have a history of pancreatitis, pancreatic disease, or renal issues to ensure safe and effective treatment.
What if you forgot to take Sitacip M 50mg/500mg Tablet ER?
If you forget to take your Sitacip M 50mg/500mg Tablet ER, try to take it as soon as you remember. But if it's near the time for your next dose, just skip the missed one and stick to your usual dosing schedule. Avoid taking a double dose to make up for the missed one. Remember to keep track of when you should take your next dose to maintain the effectiveness of your medication.
What happens if you take overdose of Sitacip M 50mg/500mg Tablet ER?
If you suspect that you or someone else has taken too much Sitacip M 50mg/500mg Tablet ER, it is crucial to seek medical help promptly. An overdose of this medication can lead to various symptoms, such as feeling cold or uncomfortable, severe nausea or vomiting, stomach pain, unexplained weight loss, muscular cramps, and fast breathing. Remember to consult your doctor or go to the nearest hospital if you experience any of these signs of an overdose.
Related lab tests
When taking Sitacip M 50mg/500mg Tablet ER, it's important to monitor your blood glucose levels regularly through various lab tests. Related lab tests for monitoring include:
1. Blood Glucose - Fasting: This test measures the glucose levels in your blood after fasting for a certain period, usually overnight. It gives an overview of your baseline glucose levels.
2. Blood Glucose - Postprandial: This test measures the glucose levels in your blood after a meal, usually taken 2 hours after eating. It helps assess how your body processes glucose after consuming food.
3. Glycosylated Hemoglobin (HbA1C): Also known as Glycated Hemoglobin, this test gives an average of your blood sugar levels over the past 2-3 months. It is a key indicator of how well your blood sugar has been controlled over time.
Monitoring these lab tests regularly while taking Sitacip M 50mg/500mg Tablet ER can help you and your healthcare provider in managing your diabetes effectively.
Additional Information
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI DIABETIC |
Action Class | - |
FAQs
Disclaimer
The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.
₹119.9
Inclusive of all taxes
Content verified by

Dr. Mansi Chaudhari
MBBS - General Medicine
Last update on 01-Oct-2024